Log In
Print this Print this

CAR T cells

  Manage Alerts
Collapse Summary General Information
Company Baylor College of Medicine
DescriptionEngineered CAR T cells
Molecular Target Glypican 3 (GPC3)
Mechanism of Action 
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today